APA (7th ed.) Citation

EJ, C., AE, R., JD, U., KE, T., JS, M., & MF, P. (2022). Adapting regulatory drug-drug interaction guidance to design clinical pharmacokinetic natural product-drug interaction studies: A NaPDI Center recommended approach. Clinical and translational science, 15(2), 322. https://doi.org/10.1111/cts.13172

Chicago Style (17th ed.) Citation

EJ, Cox, Rettie AE, Unadkat JD, Thummel KE, McCune JS, and Paine MF. "Adapting Regulatory Drug-drug Interaction Guidance to Design Clinical Pharmacokinetic Natural Product-drug Interaction Studies: A NaPDI Center Recommended Approach." Clinical and Translational Science 15, no. 2 (2022): 322. https://doi.org/10.1111/cts.13172.

MLA (9th ed.) Citation

EJ, Cox, et al. "Adapting Regulatory Drug-drug Interaction Guidance to Design Clinical Pharmacokinetic Natural Product-drug Interaction Studies: A NaPDI Center Recommended Approach." Clinical and Translational Science, vol. 15, no. 2, 2022, p. 322, https://doi.org/10.1111/cts.13172.